https://www.apollohealthco.com/wp-content/uploads/Bredesen-Toups-KaraFitzgerald.png
Make KetoFLEX 12/3™ easy, order meal delivery with Trifecta

In a recent episode of New Frontiers in Functional Medicine, hosted by Dr. Kara Fitzgerald, Drs. Dale Bredesen and Kat Toups discuss findings from their nine-month randomized controlled trial investigating a personalized precision medicine approach to cognitive decline.

The study, involving 73 participants across six clinical sites, demonstrated statistically significant improvements in several measures of cognitive function, including memory, processing speed, and overall neurocognitive performance, compared with standard care.

Drs. Bredesen and Toups explain how their multifaceted approach addresses potential contributors to cognitive decline, including metabolic dysfunction, inflammation, infections, environmental toxins, hormonal imbalances, and lifestyle factors. They also discuss the important role of nutrition, exercise, sleep, and health coaching in supporting cognitive improvement.

The conversation highlights the potential of personalized precision medicine to improve cognitive function while emphasizing the need for continued research.

Watch Here:

Share This: